Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors affecting the antimicrobial changes during treatment for acute otitis media in Japan: A retrospective cohort study using classification and regression trees (CART) analysis.
Kono M, Murakami D, Sakatani H, Okuda K, Kinoshita T, Hijiya M, Iyo T, Shiga T, Morita Y, Itahashi K, Sasagawa Y, Iwama Y, Yamaguchi T, Hotomi M. Kono M, et al. Among authors: sasagawa y. J Infect Chemother. 2024 Feb 27:S1341-321X(24)00057-6. doi: 10.1016/j.jiac.2024.02.022. Online ahead of print. J Infect Chemother. 2024. PMID: 38417479
Criteria for safety evaluation of antimicrobial agents.
Japanese Society of Chemotherapy; Antimicrobial Agents Safety Evaluation Standards Committee; Watanabe A, Tokue Y, Aoki N, Matsumoto T, Yanagihara K, Higa F, Tsuge H, Nagashima M, Matsuoka H, Sasagawa Y, Matsumoto M, Fujimaki K, Taguchi K, Ariyasu M, Yamamoto N, Kunii O, Shiba K. Japanese Society of Chemotherapy, et al. Among authors: sasagawa y. J Infect Chemother. 2011 Feb;17(1):139-47. doi: 10.1007/s10156-010-0183-0. Epub 2011 Jan 6. J Infect Chemother. 2011. PMID: 21207093 Free article. No abstract available.
Efficacy and safety of safinamide as an add-on therapy to L-DOPA for patients with Parkinson's disease: A randomized, double-blind, placebo-controlled, phase II/III study.
Hattori N, Tsuboi Y, Yamamoto A, Sasagawa Y, Nomoto M; ME2125-3 Study Group. Hattori N, et al. Among authors: sasagawa y. Parkinsonism Relat Disord. 2020 Jun;75:17-23. doi: 10.1016/j.parkreldis.2020.04.012. Epub 2020 May 4. Parkinsonism Relat Disord. 2020. PMID: 32446176 Free article. Clinical Trial.
182 results